“Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial” (2024) Swiss Medical Weekly, 154(4), p. 3762. doi:10.57187/s.3762.